BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trankle CR, Vo C, Martin E, Puckett L, Siddiqui MS, Brophy DF, Stravitz T, Guzman LA. Clopidogrel Responsiveness in Patients With Decompensated Cirrhosis of the Liver Undergoing Pre-Transplant PCI. JACC Cardiovasc Interv 2020;13:661-3. [PMID: 31883726 DOI: 10.1016/j.jcin.2019.08.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Whiteside HL, Moliterno DJ. Coronary interventions among patients with hepatic insufficiency: Encouragement to avoid a jaundiced view. Catheter Cardiovasc Interv 2020;96:811-2. [PMID: 33085200 DOI: 10.1002/ccd.29277] [Reference Citation Analysis]
2 Ostojic Z, Ostojic A, Bulum J, Mrzljak A. Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease. World J Cardiol 2021; 13(11): 599-607 [PMID: 34909126 DOI: 10.4330/wjc.v13.i11.599] [Reference Citation Analysis]
3 Ahmed T, Grigorian AY, Messerli AW. Management of Acute Coronary Syndrome in Patients with Liver Cirrhosis. Am J Cardiovasc Drugs 2022;22:55-67. [PMID: 34050893 DOI: 10.1007/s40256-021-00478-6] [Reference Citation Analysis]